Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor

Journal of Bone and Joint Surgery

Volumn 92, Issue 5, 2010, Pages 1231-1240

  DeComas, Amalia M ^a   Penfornis, Patrice ^b   Harris, Michael R ^b   Meyer, Mark S ^c   Pochampally, Radhika R ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN P63; PROTEIN S 100; VIMENTIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE TUMOR; CELL STRUCTURE; CHORDOMA; CHROMOSOME ABERRATION; EXTRA AXIAL CHORDOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAPULAR TUMOR; STAINING; TUMOR CELL; ANIMAL; CANCER TRANSPLANTATION; CASE REPORT; CULTURE TECHNIQUE; EXPERIMENTAL NEOPLASM; METHODOLOGY; MUSCLE TUMOR; PATHOLOGY; SCAPULA; TUMOR CELL LINE;

ADULT; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CHORDOMA; HUMANS; MALE; MICE; MUSCLE NEOPLASMS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; SCAPULA;

EID: 77952469589     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.I.00594     Document Type: Article

References (28)

1. Bjornsson J, Wold LE, Ebersold MJ, Laws ER. Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients. Cancer. 1993;71:735-40.
2. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12:1-11.
3. Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer. 1973;32:410-20.
4. Folpe AL, Agoff SN, Willis J, Weiss SW. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma. Am J Surg Pathol. 1999;23:1059-67.
5. Kilpatrick SE, Hitchcock MG, Kraus MD, Calonje E, Fletcher CD. Mixed tumors and myoepitheliomas of soft tissue: a clinicopathologic study of 19 cases with a unifying concept. Am J Surg Pathol. 1997;21:13-22.
6. Miettinen M, Lehto VP, Dahl D, Virtanen I. Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies. Am J Pathol. 1983;112:160-9.
7. Tirabosco R, Mangham DC, Rosenberg AE, Vujovic S, Bousdras K, Pizzolitto S, De Maglio G, den Bakker MA, Di Francesco L, Kalil RK, Athanasou NA, O'Donnell P, McCarthy EF, Flanagan AM. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol. 2008;32:572-80.
8. Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157-65.
9. DiFrancesco LM, Davanzo Castillo CA, Temple WJ. Extra-axial chordoma. Arch Pathol Lab Med. 2006;130:1871-4.
10. Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg Am. 2005;87:2211-6.
11. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.
12. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006;25:1696-708.
13. Cesinaro AM, Maiorana A, Collina G, Fano RA. Extra-axial chordoma. Report of a case with immunohistochemical study. Pathologica. 1993;85:755-60.
14. O'Donnell P, Tirabosco R, Vujovic S, Bartlett W, Briggs TW, Henderson S, Boshoff C, Flanagan AM. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. Skeletal Radiol. 2007;36:59-65.
15. Park SY, Kim SR, Choe YH, Lee KY, Park SJ, Lee HB, Jin GY, Jang KY, Lee YC. Extra-axial chordoma presenting as a lung mass. Respiration. 2009;77:219-23.
16. Fisher C. Parachordoma exists - but what is it? Adv Anat Pathol. 2000;7:141-8.
17. Bouropoulou V, Kontogeorgos G, Papamichales G, Bosse A, Roessner A, Vollmer E. Differential diagnosis of chordoma immunohistochemical aspects. Arch Anat Cytol Pathol. 1987;35:35-40.
18. Wiebe BM, Jensen K, Laursen H. Parachordoma of the sacrococcygeal region - a neuroepithelial tumor. Clin Neuropathol. 1995;14:343-6.
19. Romeo S, Hogendoorn PC. Brachyury and chordoma: the chondroid-chordoid dilemma resolved? J Pathol. 2006;209:143-6.
20. Kilpatrick SE, Limon J. Mixed tumour/ myoepithelioma/ parachordoma. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002. p 198-9.
21. Oakley GJ, Fuhrer K, Seethala RR. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol. 2008;21:1461-9.
22. Diamandopoulos GT, Miller MH, McLane MF, Evans PG. Loss or persistence of the differentiated state of simian virus 40-induced hamster tumor cells before and after serial passage in culture. Cancer Res. 1976;36(9 pt 1):3171-7.
23. Heim S, Mitelman F. Cancer cytogenetics. New York: Wiley Blackwell; 2009. p 1-31.
24. Anderson GR, Stoler DL, Brenner BM. Cancer: the evolved consequence of a destabilized genome. Bioessays. 2001;23:1037-46.
25. Lengauer C, Kinzler KW, Vogelstein B.Genetic instabilities in human cancers. Nature. 1998;396:643-9.
26. Loeb LA. A mutator phenotype in cancer. Cancer Res. 2001;61:3230-9.
27. Scheil S, Brüderlein S, Liehr T, Starke H, Herms J, Schulte M, Möller P. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer. 2001;32:203-11.
28. Larson BL, Ylöstalo J, Prockop DJ. Human multipotent stromal cells undergo sharp transition from division to development in culture. Stem Cells. 2008;26:193-201.